Vimarsana
Biggest News Aggregation in the World

Page 39 - Cell Membrane News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Membrane. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Membrane Today - Breaking & Trending Today

The North America cell line development serum market is expected to reach US$ 502.91 million in 2027 from US$ 307.29 million in 2019 - Vimarsana News

The North America cell line development serum market is expected to reach US$ 502.91 million in 2027 from US$ 307.29 million in 2019

The market is expected to grow with a CAGR of 6. 4% from 2020-2027. Increasing adoption of regenerative medicines, rising prevalence of cancer across the world, and increasing investments in R&D; by pharmaceutical and biotechnology companies are the key factors driving the growth of the North America cell line development serum market.New York, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type ; By Application ; and Country" - ht...

Source: yahoo.com
OXGENE introduces SLIM platform for discovery of antibodies against membrane proteins - Vimarsana News

OXGENE introduces SLIM platform for discovery of antibodies against membrane proteins

OXGENE introduces SLIM platform for discovery of antibodies against membrane proteins Jan 12 2021 OXGENE™, a biotechnology company offering integrated discovery and manufacturing technologies to the cell and gene therapy industry, announces the introduction of its self-labelling integral membrane (SLIM™) protein discovery system. The novel method allows for the identification of antibodies against membrane proteins in their native configuration in mammalian cells, which could catalyse the discovery of new candidates for antibody-based therapies. In SLIM display, a target membrane protein ...

Cytokine Storms Can Kill. Researchers Found Protein that Sparks Them - Vimarsana News

Cytokine Storms Can Kill. Researchers Found Protein that Sparks Them

A sugar-binding protein could fuel terrible inflammation and worsen sepsis, a disease that kills more than 270,000 people every year in the US alone,...

Scientists gain new insight into how the immune system can be better used to destroy cancer cells - Vimarsana News

Scientists gain new insight into how the immune system can be better used to destroy cancer cells

Scientists gain new insight into how the immune system can be better used to destroy cancer cells Scientists at the University of Southampton's Centre for Cancer Immunology have gained new insight into how the immune system can be better used to find and kill cancer cells. Working with BioInvent International, a team led by Professor Mark Cragg and Dr Jane Willoughby from the Antibody and Vaccine Group, based at the Centre, have shown that antibodies, designed to target the molecule OX40, give a more active immune response when they bind closer to the cell membrane and can be modified to atta...

High-affinity SARS-CoV-2 RBD drives mutation spread, forms basis of new COVID-19 inhibitor - Vimarsana News

High-affinity SARS-CoV-2 RBD drives mutation spread, forms basis of new COVID-19 inhibitor

Now, an intriguing recent study appeared on the bioRxiv * preprint server describes the use of in vitro evolution to elicit affinity maturation of the viral receptor-binding domain (RBD) of the spike protein to bind the host cell angiotensin-converting enzyme 2 (ACE2) with greater affinity.